2013 Fiscal Year Final Research Report
A role for ATOX1 in 5q- syndrome
Project/Area Number |
24659467
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Single-year Grants |
Research Field |
Hematology
|
Research Institution | Keio University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
OKAMOTO Shinichiro 慶應義塾大学, 医学部, 教授 (50160718)
|
Project Period (FY) |
2012-04-01 – 2014-03-31
|
Keywords | 5q-症候群 / 骨髄異形成症候群 / ATOX1 / 造血幹細胞 |
Research Abstract |
5q- syndrome is a subtype of myelodysplastic syndrome characterized by a deletion of chromosome 5q33. To elucidate molecular pathogenesis of 5q- syndrome, we focused on ATOX1, a cupper chaperone located in the common deleted region of 5q33. Frequencies of hematopoietic stem cells (HSCs), multipotent hematopoietic progenitors, and lineage-committed progenitors in the bone marrow were normal in ATOX1-/- mice, and ATOX1-/- HSCs maintained normal self-renewal and long-term repopulating capacities. These results suggest that ATOX1 is not essential for HSC function and hematopoietic differentiation, and that ATOX1 has little, if any, roles in 5q- syndrome.
|
-
[Journal Article] Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients2014
Author(s)
Sakurai M, Kunimoto H, Watanabe N, Fukuchi Y, Yuasa S, Yamazaki S, Nishimura T, Sadahira K, Fukuda K, Okano H, Nakauchi H, Morita Y, Matsumura I, Kudo K, Ito E, Ebihara Y, Tsuji K, Harada Y, Harada H, Okamoto S, Nakajima H.
-
Journal Title
DOI
Peer Reviewed
-
-
[Journal Article] Plzf drives MLL-fusion-mediated leukemogenesis specifically in long term hematopoietic stem cells2013
Author(s)
Ono R, Masuya M, Nakajima H, Enomoto Y, Miyata E, Nakamura A, Ishii S, Suzuki K, Shibata-Minoshima F, Katayama N, Kitamura T, Nosaka T.
-
Journal Title
Blood
Volume: 122
Pages: 1271-83
Peer Reviewed
-
-
-
-
[Presentation] The Genetic Landscape of FPD/AML Revealed CDC25C Mutation as a Driver that Promotes Malignant Transformation2013
Author(s)
Akihide Yoshimi, Takashi Toya, Masahiro Nakagawa, Masahito Kawazu, Yasuhito Nannya, Motoshi Ichikawa, Shunya Arai, Hironori Harada, Kensuke Usuki, Yasuhide Hayashi, Etsuro Ito, Keita Kirito, Hideaki Nakajima, Hiroyuki Mano, Mineo Kurokawa
Organizer
55th Annual Meeting of American Society of Hematology, Simultaneous Session
Place of Presentation
米国、ニューオーリンズ
Year and Date
2013-12-09
-
[Presentation] Chemo-Immunotherapy With Hyper-CVAD/MA and Rituximab For B-Cell Lymphomas Leads To Prolonged Immune Suppression Compared To Conventional Treatment With R-CHOP2013
Author(s)
Eri Matsuki, Taku Kikuchi, Norisato Hashimoto, Shunsuke Souma, Sumiko Kohashi, Takaaki Toyama, Masatoshi Sakurai, Daiki Karigane, Daichi Abe, Takayuki Shimizu, Kenji Yokoyama, Hideaki Nakajima, Shinichiro Okamoto
Organizer
55th Annual Meeting of American Society of Hematology, Simultaneous Session
Place of Presentation
米国、ニューオーリンズ
Year and Date
2013-12-09
-
[Presentation] Impaired emergence of hematopoietic progenitors and defective megakaryocyte differentiation from FPD/AML-derived induced pluripotent stem cells2013
Author(s)
Masatoshi Sakurai, Hiroyoshi Kunimoto, Naohide Watanabe, Yumi Fukuchi, Shinsuke Yuasa, Keiichi Fukuda, Satoshi Yamazaki, Hiromitsu Nakauchi, Yasuhiro Ebihara, Koichiro Tsuji, Etsuro Ito, Yuka Harada, Hironori Harada, Shinichiro Okamoto, Hideaki Nakajima
Organizer
EMBO Workshop-RUNX transcription factors in development and disease
Place of Presentation
ドイツ、Wilsede
Year and Date
2013-06-17
-
[Presentation] Impaired hematopoietic differentiation of iPSCs derived from patients with FPD/AML2012
Author(s)
Masatoshi Sakurai, Hiroyoshi Kunimoto, Naohide Watanabe, Yumi Fukuchi, Ken Sadahira, Shinsuke Yuasa, Keiichi Fukuda, Satoshi Yamazaki, Hiromitsu Nakauchi, Yasuhiro Ebihara, Koichiro Tsuji, Etsuro Ito, Yuka Harada, Hironori Harada, Shinichiro Okamoto, Hideaki Nakajima
Organizer
54th Annual Meeting of American Society of Hematology, Simultaneous Session
Place of Presentation
米国、アトランタ
Year and Date
2012-12-10
-
-
-